Translational Research Grant supports North Carolina researchers advancing university-held life sciences inventions toward commercial products that solve real-world problems through milestone-based research.
Funder: North Carolina Biotechnology Center
Due Dates: August 5, 2026, noon (FY27 Cycle 1) | January 27, 2027, noon (FY27 Cycle 2)
Funding Amounts: Up to $130,000 plus a $14,000 project manager supplement ($144,000 total) for up to 24 months
Summary: Supports translational research advancing university-held life sciences inventions toward commercial products that solve real-world problems.
Key Information: Institutional IP must be disclosed and uncommitted to third parties, with a four-member core project team required.
The North Carolina Biotechnology Center’s Translational Research Grant (TRG) supports researchers at North Carolina universities and nonprofit research organizations exploring commercial applications or initiating early commercial development of university-held life sciences inventions. Projects must have the potential to solve a real-world problem through a commercial life sciences product.
The program funds team-driven, milestone-based scientific work that advances discoveries toward product development. Priorities include generating data that addresses technical or regulatory milestones, resolves potential licensee or investor concerns, and reduces technology risk. Projects should support go/no-go decisions about further development or intellectual property protection and enable institutional licensing efforts. Examples include proof-of-concept studies, validated-target compound screening, prototypes, scale-up pilots, optimization, and independent confirmation of crucial preliminary findings.